# FSS #36F79727D004E

Interim Agreement for Pharmaceutical Products via Federal Supply Schedule

**Buyer:** Department of Veterans Affairs

**Award Amount:** $25,000.00
**Ceiling:** $25,000.00

**Awarded:** October 16, 2026
**Period of Performance:** Oct 16, 2026 - Apr 14, 2027

**Identifier:** 36F79727D004E
**NAICS:** 325412

This award represents an interim agreement contract under the Federal Supply Schedule (FSS) Schedule 65 I B, focusing on drugs, pharmaceuticals, and hematology-related products. The contract recipient, Chirhoclin, Inc., is a company specializing in pharmaceutical products relevant to hematology, supporting governmental healthcare needs. The procurement covers the supply of vital pharmaceutical and hematology-related products to meet agency requirements, ensuring continued access to these essential medical products. This agreement is critical for maintaining a stable supply chain of pharmaceuticals in the public health sector. The work scope involves delivering specific pharmaceutical products as outlined in the FSS Schedule 65 I B, facilitating streamlined purchasing procedures for federal agencies. Awarded through the Federal Supply Schedule vehicle, this contract likely leveraged an established sourcing mechanism rather than a traditional competitive bidding process, enhancing procurement efficiency. The multi-year but relatively short-term performance period spans from late 2026 to early 2027, highlighting its interim nature as a bridge arrangement. No key subcontractors or previous related contracts are indicated for this award.

### Description

INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS

[View original record](https://www.usaspending.gov/award/CONT_IDV_36F79727D004E_3600)